Optomed Oyj

HEL:OPTOMED.HE

3.16 (EUR) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q3
Revenue 3.5053.3273.664.2183.7443.4784.0133.73.7333.2143.5523.3424.0123.9444.0413.3382.5973.0344.3293.5513.8583.244.6883.362
Cost of Revenue 3.9383.7841.1921.3711.2921.0021.2271.5761.5841.0611.2011.141.3111.4491.2721.1050.7771.0591.5951.2811.41.011.5791.424
Gross Profit -0.433-0.4572.4682.8472.4522.4762.7862.1242.1492.1532.3512.2022.7012.4952.7692.2331.821.9752.7342.272.4582.233.1091.938
Gross Profit Ratio -0.124-0.1370.6740.6750.6550.7120.6940.5740.5760.670.6620.6590.6730.6330.6850.6690.7010.6510.6320.6390.6370.6880.6630.576
Reseach & Development Expenses 0.0520.0790.0430.0540.0430.4460.0620.0360.0820.5850.540.4650.6510.6281.6120.2790.3690.5151.4930.4210.480.3641.320
General & Administrative Expenses 1.180.5610.5760.8490.5230.5620.4640.5030.55100.6910002.1610002.1430001.8250
Selling & Marketing Expenses 0.2130.0950.1850.1110.1920.1470.2060.20.20400.6740000.4220000.4890000.5090
SG&A 1.3930.6560.7610.960.7150.6350.670.7030.7550.6751.3650.6590.7290.7442.5831.4841.7581.9162.6321.5911.8241.7412.3341.239
Other Expenses 0.00900.021-0.0060.0343.5192.9232.7982.6663.6150.0573.093.5593.3463.3642.5112.7933.0362.7673.3793.2472.8932.6582.275
Operating Expenses 1.4450.7353.7863.453.4613.5193.6553.5373.5033.6154.5313.093.5593.3463.3642.5112.7933.0362.7673.3793.2472.8932.6582.275
Operating Income -1.878-1.192-1.319-0.603-1.009-1.043-0.869-1.267-1.354-1.462-2.182-0.888-0.859-0.851-0.594-0.278-0.973-1.061-0.033-1.109-0.789-0.6640.453-0.337
Operating Income Ratio -0.536-0.358-0.36-0.143-0.269-0.3-0.217-0.342-0.363-0.455-0.614-0.266-0.214-0.216-0.147-0.083-0.375-0.35-0.008-0.312-0.205-0.2050.097-0.1
Total Other Income Expenses Net 0.0620.094-0.2310.144-0.325-0.134-0.548-0.130.0060.0720.2260.035-0.1280.216-0.266-0.143-0.023-0.209-0.107-0.142-0.217-0.074-0.102-0.102
Income Before Tax -1.816-1.098-1.55-0.459-1.334-1.177-1.417-1.397-1.348-1.39-1.956-0.853-0.884-0.635-0.663-0.432-0.996-1.27-0.101-1.251-1.006-0.5940.351-0.439
Income Before Tax Ratio -0.518-0.33-0.423-0.109-0.356-0.338-0.353-0.378-0.361-0.432-0.551-0.255-0.22-0.161-0.164-0.129-0.384-0.419-0.023-0.352-0.261-0.1830.075-0.131
Income Tax Expense -0.023-0.007-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.019-0.011-0.02-0.02-0.02-0.0420.004-0.019-0.019-0.0980.036
Net Income -1.793-1.09-1.53-0.439-1.314-1.157-1.397-1.377-1.328-1.37-1.936-0.833-0.864-0.616-0.652-0.412-0.976-1.25-0.058-1.256-0.987-0.5750.449-0.476
Net Income Ratio -0.512-0.328-0.418-0.104-0.351-0.333-0.348-0.372-0.356-0.426-0.545-0.249-0.215-0.156-0.161-0.123-0.376-0.412-0.013-0.354-0.256-0.1770.096-0.142
EPS -0.1-0.064-0.092-0.027-0.084-0.076-0.095-0.097-0.096-0.1-0.14-0.062-0.065-0.046-0.049-0.032-0.083-0.12-0.007-0.095-0.075-0.0440.06-0.036
EPS Diluted -0.1-0.064-0.092-0.027-0.084-0.076-0.095-0.097-0.096-0.1-0.14-0.062-0.065-0.046-0.049-0.032-0.083-0.12-0.007-0.095-0.075-0.0440.06-0.036
EBITDA -1.194-0.649-0.7020.268-0.424-0.445-0.3410.29-0.51-0.81-1.264-0.2490.28-0.0760.1360.218-0.246-0.5010.589-0.546-0.2250.030.9840.155
EBITDA Ratio -0.341-0.195-0.1920.064-0.113-0.128-0.0850.078-0.137-0.252-0.356-0.0750.07-0.0190.0340.065-0.095-0.1650.136-0.154-0.0580.0090.210.046